Amphastar Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03209R1032

SecurityAMPH / Amphastar Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership65,540 shares
Latest Disclosed Value $ 1,283,929
Citadel Advisors Llc ownership in AMPH / Amphastar Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 65,540 shares of Amphastar Pharmaceuticals, Inc. (US:AMPH) valued at $1,283,929 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 228,724 shares of Amphastar Pharmaceuticals, Inc.. This represents a change in shares of -71.35% during the quarter. The current value of the position is $1,293,760 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AMPH) in the form of stock options. The firm currently holds call options representing 19,900 of underlying shares valued at $389,841 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AMPH / Amphastar Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 65,540 -163,184 -71.35 1,284 -79.05 0.0002
2026-02-17 2025-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 228,724 1,949 0.86 6,125 1.36 0.0009
2025-11-14 2025-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 226,775 -65,570 -22.43 6,044 -9.97 0.0009
2025-08-14 2025-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 292,345 136,366 87.43 6,712 48.46 0.0012
2025-05-15 2025-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 155,979 15,566 11.09 4,522 -13.27 0.0009
2025-02-14 2024-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 140,413 5,176 3.83 5,214 -20.57 0.0009
2024-11-14 2024-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 135,237 -127,914 -48.61 6,563 -37.65 0.0013
2024-08-14 2024-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 263,151 195,454 288.72 10,526 254.17 0.0021
2024-05-15 2024-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 67,697 -48,502 -41.74 2,973 -58.64 0.0006
2024-02-14 2023-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 116,199 -12,516 -9.72 7,187 21.41 0.0014
2023-11-14 2023-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 128,715 -49,235 -27.67 5,920 -42.12 0.0013
2023-08-14 2023-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 177,950 146,609 467.79 10,227 770.30 0.0021
2023-05-15 2023-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 31,341 -11,166 -26.27 1,175 -1.34 0.0003
2023-02-14 2022-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 42,507 -132,758 -75.75 1,191 -75.82 0.0003
2022-11-14 2022-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 175,265 133,867 323.37 4,925 242.01 0.0011
2022-08-15 2022-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 41,398 -196,485 -82.60 1,440 -83.14 0.0004
2022-05-16 2022-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 237,883 24,361 11.41 8,540 71.73 0.0018
2022-02-14 2021-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 213,522 213,522 4,973 0.0010
2022-03-11 2021-09-30 13F/A-1 AMPHASTAR PHARMACEUTICALS IN COM 03209R103 0 -24,373 -100.00 0 -100.00
2021-11-15 2021-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 0 -24,373 0
2021-08-16 2021-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 24,373 -15,056 -38.19 492 -31.86 0.0001
2021-05-21 2021-03-31 13F/A-1 AMPHASTAR PHARMACEUTICALS IN COM 03209R103 39,429 -30,709 -43.78 722 -48.79 0.0002
2021-05-17 2021-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 39,429 -30,709 722 0.0002
2021-02-16 2020-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 70,138 16,164 29.95 1,410 39.33 0.0004
2020-11-16 2020-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM 03209R103 53,974 16,234 43.02 1,012 19.34 0.0003
2020-08-14 2020-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 37,740 -48,475 -56.23 848 -33.75 0.0003
2020-05-15 2020-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 86,215 86,215 1,280 0.0006
2020-02-14 2019-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 0 -132,053 -100.00 0 -100.00
2019-11-14 2019-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 132,053 74,767 130.52 2,618 116.54 0.0012
2019-08-14 2019-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 57,286 43,126 304.56 1,209 318.34 0.0006
2019-05-15 2019-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 14,160 -17,854 -55.77 289 -54.63 0.0001
2019-02-14 2018-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 32,014 32,014 637 0.0003
2018-08-14 2018-06-30 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 0 -34,180 -100.00 0 -100.00
2018-05-14 2018-03-31 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 34,180 34,180 641 0.0004
2018-05-11 2018-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 34,180 34,180 641
2017-11-09 2017-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 0 -92,576 -100.00 0 -100.00
2017-08-11 2017-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 92,576 -262,990 -73.96 1,653 -67.94 0.0014
2017-05-12 2017-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 355,566 337,079 1,823.33 5,156 1,412.02 0.0047
2017-02-10 2016-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 18,487 -47,633 -72.04 341 -72.81 0.0003
2017-01-31 2016-09-30 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 66,120 -149,111 -69.28 1,254 -63.85 0.0013
2016-11-10 2016-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 66,120 1,254
2017-01-31 2016-06-30 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 215,231 202,862 1,640.08 3,469 2,243.92 0.0039
2016-08-12 2016-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 215,231 3,469
2017-01-31 2016-03-31 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 12,369 2,033 19.67 148 0.68 0.0002
2016-05-13 2016-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 12,369 148
2017-01-31 2015-12-31 13F/A-1 AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 10,336 10,336 -85.97 147 -88.65 0.0002
2016-02-12 2015-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 10,336 147
2015-11-16 2015-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 0 -73,670 -100.00 0 -100.00
2015-08-14 2015-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 73,670 15,508 26.66 1,295 48.85 0.0011
2015-05-15 2015-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 58,162 7,778 15.44 870 48.72 0.0010
2015-02-17 2014-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 50,384 34,684 220.92 585 219.67 0.0007
2014-11-14 2014-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn 03209R103 15,700 15,700 183 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 19,900 61.79 390 18.24 n/a n/a n/a
2026-02-17 2025-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 12,300 -18.54 329 -18.16 n/a n/a n/a
2025-11-14 2025-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 15,100 -17.49 402 -4.29 n/a n/a n/a
2025-08-14 2025-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 18,300 -12.02 420 -30.23 n/a n/a n/a
2025-05-15 2025-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 20,800 70.49 603 33.19 n/a n/a n/a
2025-02-14 2024-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 12,200 -50.41 453 -62.11 n/a n/a n/a
2024-11-14 2024-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 24,600 232.43 1,194 303.04 n/a n/a n/a
2024-08-14 2024-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 7,400 -50.34 296 -54.74 n/a n/a n/a
2024-05-15 2024-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 14,900 31.86 654 -6.30 n/a n/a n/a
2024-02-14 2023-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 11,300 22.83 699 65.01 n/a n/a n/a
2023-11-14 2023-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 9,200 33.33 423 6.82 n/a n/a n/a
2023-08-14 2023-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 6,900 21.05 397 85.92 n/a n/a n/a
2023-05-15 2023-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 5,700 -29.63 214 -5.75 n/a n/a n/a
2023-02-14 2022-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 8,100 -61.79 227 -62.08 n/a n/a n/a
2022-11-14 2022-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 21,200 -36.53 596 -48.71 n/a n/a n/a
2022-08-15 2022-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Call 33,400 138.57 1,162 131.01 n/a n/a n/a
2022-05-16 2022-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Call 14,000 503 n/a n/a n/a
2019-08-14 2019-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 10,800 221 n/a n/a n/a
2016-05-13 2016-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A AMPHASTAR PHARMACEUTICALS IN Cmn Call 300 4 n/a n/a n/a
2016-02-12 2015-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 300 4 n/a n/a n/a
2015-11-16 2015-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Call 2,100 37 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 11,900 -3.25 317 12.41 n/a n/a n/a
2025-08-14 2025-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 12,300 6.03 282 -16.07 n/a n/a n/a
2025-05-15 2025-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 11,600 46.84 336 14.68 n/a n/a n/a
2025-02-14 2024-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 7,900 125.71 293 73.37 n/a n/a n/a
2024-11-14 2024-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 3,500 -20.45 170 -3.98 n/a n/a n/a
2024-08-14 2024-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 4,400 -63.93 176 -67.10 n/a n/a n/a
2024-05-15 2024-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 12,200 41.86 536 0.75 n/a n/a n/a
2024-02-14 2023-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 8,600 290.91 532 425.74 n/a n/a n/a
2023-11-14 2023-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 2,200 -45.00 101 -55.90 n/a n/a n/a
2023-08-14 2023-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 4,000 25.00 230 90.83 n/a n/a n/a
2023-05-15 2023-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 3,200 113.33 120 185.71 n/a n/a n/a
2023-02-14 2022-12-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 1,500 42 n/a n/a n/a
2022-11-14 2022-09-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 12,300 38.20 428 33.75 n/a n/a n/a
2022-05-16 2022-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 8,900 320 n/a n/a n/a
2021-08-16 2021-06-30 13F AMPHASTAR PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AMPHASTAR PHARMACEUTICALS IN COM Put 12,000 220 n/a n/a n/a
2021-05-17 2021-03-31 13F AMPHASTAR PHARMACEUTICALS IN COM Put 12,000 220 n/a n/a n/a
2020-11-16 2020-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 16,100 362 n/a n/a n/a
2016-05-13 2016-03-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A AMPHASTAR PHARMACEUTICALS IN Cmn Put 300 0.00 4 n/a n/a n/a
2016-02-12 2015-12-31 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 300 4 n/a n/a n/a
2015-11-16 2015-09-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F AMPHASTAR PHARMACEUTICALS IN Cmn Put 1,300 23 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.